Cipla Ltd

Cipla Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Cipla Ltd

₹ 1,495 -0.30%
19 May 9:42 a.m.
cipla.com BSE: 500087 NSE: CIPLA
About

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157)

Key Points

Market Leadership[1]
# 3rd largest in the India domestic Rx market
# Leadership in Gx
# 1st rank in Respiratory
# Top 5 in Urology and Anti-infectives.
# Over 5 Lac+ no of downloads - Digital Breathe free
# 7,500+ field force detailing to HCPs across the country – 85% of physicians prescribe at least one Cipla product.
# 3rd largest player in private Rx market in SAGA
# Fastest growing generic player in North America.

Website BSE NSE
  • Market Cap ₹ 1,20,754 Cr.
  • Current Price ₹ 1,495
  • High / Low ₹ 1,702 / 1,310
  • Stock P/E 22.9
  • Book Value ₹ 386
  • Dividend Yield 0.87 %
  • ROCE 23.3 %
  • ROE 18.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 30.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 24.8%

Cons

  • The company has delivered a poor sales growth of 9.97% over past five years.
  • Promoter holding has decreased over last 3 years: -4.43%
  • Working capital days have increased from 158 days to 227 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
5,260 5,375 5,829 5,810 5,739 6,329 6,678 6,604 6,163 6,694 7,051 7,073 6,730
4,511 4,232 4,526 4,403 4,566 4,835 4,944 4,856 4,847 4,978 5,165 5,084 5,192
Operating Profit 750 1,143 1,302 1,408 1,174 1,494 1,734 1,748 1,316 1,716 1,886 1,989 1,538
OPM % 14% 21% 22% 24% 20% 24% 26% 26% 21% 26% 27% 28% 23%
7 103 123 114 -48 136 176 -10 249 160 191 222 289
Interest 18 18 26 32 34 16 26 30 18 18 15 15 14
Depreciation 290 254 299 272 346 239 290 233 288 247 272 280 309
Profit before tax 448 975 1,100 1,218 745 1,375 1,594 1,474 1,259 1,611 1,789 1,916 1,504
Tax % 16% 28% 28% 34% 30% 28% 28% 28% 26% 27% 27% 17% 19%
371 706 797 808 522 998 1,155 1,068 932 1,175 1,305 1,575 1,214
EPS in Rs 4.49 8.51 9.78 9.92 6.51 12.33 14.01 13.08 11.63 14.58 16.13 19.45 15.13
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
10,173 11,345 13,790 14,394 15,156 16,362 17,132 19,160 21,763 22,753 25,774 27,548
8,026 9,183 11,310 11,898 12,329 13,265 13,926 14,907 17,211 17,726 19,483 20,420
Operating Profit 2,147 2,163 2,480 2,496 2,826 3,097 3,206 4,252 4,553 5,027 6,291 7,128
OPM % 21% 19% 18% 17% 19% 19% 19% 22% 21% 22% 24% 26%
251 164 208 208 280 477 344 266 99 293 552 862
Interest 146 168 207 159 114 168 197 161 106 110 90 62
Depreciation 373 505 754 1,323 1,323 1,326 1,175 1,068 1,052 1,172 1,051 1,107
Profit before tax 1,880 1,654 1,727 1,222 1,669 2,079 2,178 3,290 3,493 4,038 5,702 6,821
Tax % 25% 24% 19% 15% 15% 27% 29% 27% 27% 30% 27% 22%
1,404 1,229 1,383 1,035 1,417 1,492 1,500 2,389 2,547 2,833 4,154 5,269
EPS in Rs 17.29 14.71 16.93 12.51 17.52 18.96 19.18 29.82 31.19 34.71 51.05 65.28
Dividend Payout % 12% 14% 12% 16% 17% 16% 21% 17% 16% 24% 25% 25%
Compounded Sales Growth
10 Years: 9%
5 Years: 10%
3 Years: 8%
TTM: 7%
Compounded Profit Growth
10 Years: 16%
5 Years: 30%
3 Years: 27%
TTM: 25%
Stock Price CAGR
10 Years: 8%
5 Years: 19%
3 Years: 15%
1 Year: 7%
Return on Equity
10 Years: 13%
5 Years: 15%
3 Years: 16%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 161 161 161 161 161 161 161 161 161 161 161 162
Reserves 9,890 10,641 11,356 12,383 14,068 14,851 15,602 18,165 20,680 23,246 26,545 31,032
1,248 1,703 5,202 4,113 4,098 4,316 2,816 2,014 1,056 803 559 438
2,102 3,166 4,331 4,213 4,346 4,433 4,843 4,514 4,960 5,089 5,267 5,755
Total Liabilities 13,400 15,670 21,049 20,869 22,673 23,762 23,423 24,855 26,857 29,300 32,533 37,387
6,496 6,830 9,368 9,492 9,950 9,608 9,683 9,516 9,683 9,160 9,607 10,360
CWIP 442 581 2,061 1,683 981 676 825 969 766 1,093 1,153 1,213
Investments 709 640 759 973 1,259 2,554 1,471 2,710 2,551 3,662 5,449 7,933
5,753 7,620 8,862 8,721 10,483 10,923 11,444 11,661 13,857 15,384 16,323 17,882
Total Assets 13,400 15,670 21,049 20,869 22,673 23,762 23,423 24,855 26,857 29,300 32,533 37,387

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,563 1,173 1,741 2,382 1,463 1,691 3,068 3,755 3,326 3,238 4,134 5,005
-1,265 -950 -4,533 -1,304 -834 -1,688 114 -2,374 -1,858 -2,376 -2,982 -3,691
-266 165 3,104 -1,326 -385 -349 -2,949 -1,240 -1,600 -958 -1,200 -1,293
Net Cash Flow 33 388 312 -248 243 -345 234 141 -132 -97 -49 21

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 59 64 62 65 75 93 83 66 57 65 68 73
Inventory Days 273 329 273 239 271 250 267 232 230 228 217 231
Days Payable 92 126 106 108 142 123 139 103 108 112 102 116
Cash Conversion Cycle 239 267 230 196 204 220 211 195 180 181 182 188
Working Capital Days 126 133 121 111 129 143 122 106 103 122 125 227
ROCE % 19% 15% 13% 7% 9% 11% 12% 17% 17% 18% 23% 23%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
33.61% 33.61% 33.61% 33.55% 33.46% 33.46% 33.46% 33.46% 30.91% 30.93% 29.19% 29.20%
27.65% 27.69% 28.39% 27.42% 25.49% 25.74% 25.73% 25.82% 27.82% 28.80% 26.65% 26.28%
21.33% 21.47% 20.87% 21.83% 24.05% 23.90% 24.05% 24.15% 24.66% 23.95% 27.49% 27.89%
0.00% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.23% 0.26%
17.40% 17.00% 16.91% 16.99% 16.76% 16.68% 16.53% 16.36% 16.40% 16.11% 16.43% 16.36%
No. of Shareholders 4,18,9103,88,8644,04,1824,75,2934,66,5154,26,8634,25,7314,36,1544,63,5694,70,2345,25,1145,43,420

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls